People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

Patients with acromegaly make too much growth hormone, which causes them to grow disproportionately large bones, organs and ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...

Acromegaly is a rare, chronic endocrine disorder characterized by excessive secretion of growth hormone (GH), most commonly resulting from a benign pituitary adenoma.

Crinetics shares PATHFNDR trial data showing oral Palsonify maintained hormone and symptom control in acromegaly patients ...

Acromegaly is an endocrine disorder characterized by sustained hypersecretion of GH, with concomitantly increased levels of IGF-I. Historically, acromegaly is associated with premature mortality ...

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...

Adults treated for acromegaly at a medical center in Turkey do not have an increased risk for cancer compared with the general population, according to study findings published in Endocrine ...

Acromegaly is an endocrine disorder characterized by excessive soft tissue and bone growth, and is caused by excessive levels of growth hormone secreted by the pituitary gland. These excessive ...